ArticleClinical genitourinary cancer2022

Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma.

Yung Lyou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.